Alemtuzumab
CD52-directed Cytolytic Antibody
Alemtuzumab Injection
| Dosage | Brand | Image |
|---|---|---|
| 1 ML alemtuzumab 30 MG/ML Injection | Generic | |
| 1 ML alemtuzumab 30 MG/ML Injection [Campath] | Generic | |
| 1.2 ML alemtuzumab 10 MG/ML Injection | Generic | |
| 1.2 ML alemtuzumab 10 MG/ML Injection [Lemtrada] | Generic |
Alemtuzumab desired effects:
- Increased Lymphocyte Cell Destruction
Alemtuzumab drug classes:
- CD52-directed Cytolytic Antibody
Alemtuzumab pharmacologic actions:
- Antineoplastic Agents, Immunological
Alemtuzumab mechanism of action:
- Antibody-Receptor Interactions
- CD52-directed Antibody Interactions
